24
Participants
Start Date
October 31, 2011
Primary Completion Date
January 31, 2012
Study Completion Date
January 31, 2012
ALO-02 (Oxycodone Naltrexone)
single dose of ALO-02 capsule under fasting condition
ALO-02 (Oxycodone Naltrexone)
single dose of ALO-02 capsule under fed condition
ALO-02 (Oxycodone Naltrexone)
ALO-02 with the ALO-02 pellets sprinkled on applesauce, and administered under fasting conditions.
Pfizer Investigational Site, New Haven
Lead Sponsor
Pfizer
INDUSTRY